Relative Bioavailability Study of HU6
Clinical trial NCT06486558 · COMPLETED
Trial details
- NCT number
- NCT06486558
- Sponsor
- Rivus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-24
- Primary completion
- 2024-11-15
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.